cd38 inhibitor and 5-amino-1mq synergy nad+ Inhibition of enzymatic activity enhances CAR-T cell immune-therapeutic efficacy by repressing glycolytic metabolism Heavy-chain antibody targeting of CD38
Heavy chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs Scientific Reports A systems approach to NAD+ restoration ScienceDirect The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Rapid Discovery of CD38 Inhibitor via DNA Encoded Natural Product Library Screening
Pay in 4 interest-free payments of $6.64 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



